title: Have the recently completed phase III trials significantly impacted adjuvant treatment choices for stage II breast carcinoma?
authors.affiliation: Cancer Center Methodist Hospitals of Dallas, TX, USA.
authors.forename: E
authors.initials: E
authors.lastname: Middleman
authors.forename: M P
authors.initials: MP
authors.lastname: Castro
authors.forename: W
authors.initials: W
authors.lastname: Gradishar
mesh_terms: D001943:Breast Neoplasms / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003657:Decision Making; D006801:Humans